(Cell, Oct 2013) New theoretical models suggest that targeting the dynamic features of a signaling network, rather than its individual components, will lead to drugs with reduced side effects.

(Stem Cells, Dec 2012) Researchers suggest that resistance to drug treatments may be a normal part of a cancer stem cell’s life.